iRhythm Technologies (NSDQ:IRTC) has big plans for 2022 and its remote external electrocardiogram monitors as the medical device developer gears up for growth.
President and CEO Quentin Blackford is looking to hire an international general manager among other roles in the coming months, he told Medical Design & Outsourcing after presenting at this month’s 2022 J.P. Morgan Healthcare Conference. The conference was a chance for the former Dexcom COO to lay out his vision for profitably scaling iRhythm.
Asked by MDO whether Blackford is planning a reorganization or restructuring after discussing the cost-consciousness side of his growth plans, an external spokesperson offered more details from the CEO.
“At a leadership level, we are actively structuring our C-suite in order to create long-term sustainable growth,” Blackford said. “The goal is to enable iRhythm to be a global organization that creates significant value for both the healthcare system and our investors. We’ve recently appointed some talented industry veterans to COO, CCO and GC, and expect to hire additional roles over the next couple of months, such as an international GM.”
This article was original published here.